Glutathione S-Transferase π Amplification is Associated with Cisplatin Resistance in Head and Neck Squamous Cell Carcinoma Cell Lines and Primary Tumors

Cancer Research

Volumn 63, Issue 23, 2003, Pages 8097-8102

  Cullen, Kevin J ^a,b   Newkirk, Kenneth A ^a,b   Schumaker, Lisa M ^a   Aldosari, Naji ^a   Rone, Janice D ^a   Haddad, Bassem R ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DNA; FLUOROURACIL; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; UNCLASSIFIED DRUG;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL CULTURE; CANCER SURVIVAL; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; DNA DETERMINATION; DRUG RESPONSE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HEAD CANCER; HUMAN; HUMAN CELL; IC 50; IMMUNOHISTOCHEMISTRY; NECK CANCER; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FLUOROURACIL; GENE AMPLIFICATION; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; NUCLEIC ACID HYBRIDIZATION;

EID: 0346365372     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Mantovani, G., Maccio, A., Massa, E., Mulas, C., Mudu, M. C., Massidda, S., Massa, D., Murgia, V., Ferreli, L., Succu, G., Astara, G., Proto, E., Tore, G., Mura, M., and Maxia, G. Phase II study of induction chemotherapy followed by concomitant chemoradiotherapy in advanced head and neck cancer: clinical outcome, toxicity and organ/function preservation. Int. J. Oncol., 16: 1227-1233, 2000.
2. Jacobs, C., Lyman, G., Velez-Garcia, E., Sridhar, K. S., Knight, W., Hochster, H., Goodnough, L. T., Mortimer, J. E., Einhorn, L. H., Schacter, L., Cherng, N., Dalton, T., Burroughs, J., and Rozencweig, M. A Phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck. J. Clin. Oncol., 10: 257-263, 1992.
3. Kartalou, M., and Essigmann, J. M. Mechanisms of resistance to cisplatin. Mutat. Res., 478 (1-2): 23-43, 2001.
4. Mannervik, B. The enzymes of glutathione metabolism: an overview. Biochemic. Soc. Trans., 15: 717-718, 1987.
5. Tew, K. D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res., 54: 4313-4320, 1994.
6. Luk, C., Tsao, M. S., Bayani, J., Shepherd, F., and Squire, J. A. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization. Cancer Genet. Cytogenet., 125: 87-99, 2001.
7. Weiss, M. M., Kuipers, E. J., Hermsen, M. A., van Grieken, N. C., Offerhaus, J., Baak, J. P., Meuwissen, S. G., and Meijer, G. A. Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications. J. Pathol., 199: 157-165, 2003.
8. Meredith, S. D., Levine, P. A., Burns, J. A., Gaffey, M. J., Boyd, J. C., Weiss, L. M., Erickson, N. L., and Williams, M. E. Chromosome 11q13 amplification in head and neck squamous cell carcinoma. Association with poor prognosis. Arch. Otolaryngol. Head Neck Surg., 121: 790-794, 1995.
9. Bockmuhl, U., Schluns, K., Kuchler, I., Petersen, S., and Petersen, I. Genetic imbalances with impact on survival in head and neck cancer patients. Am. J. Pathol., 157: 369-375, 2000.
10. Gaffey, M. J., Iezzoni, J. C., Meredith, S. D., Boyd, J. C., Stoler, M. H., Weiss, L. M., Zukerberg, L. R., Levine, P. A., Arnold, A., and Williams, M. E. Cyclin D1 (PRAD1, CCND1) and glutathione S-transferase π gene expression in head and neck squamous cell carcinoma. Hum. Pathol., 26: 1221-1226, 1995.
11. Yellin, S. A., Davidson, B. J., Pinto, J. T., Sacks, P. G., Qiao, C., and Schantz, S. P. Relationship of glutathione and glutathione S-transferase to cisplatin sensitivity in human head and neck squamous carcinoma cell lines. Cancer Lett., 85: 223-232, 1994.
12. Williams, M. E., Gaffey, M. J., Weiss, L. M., Wilczynski, S. P., Schuuring, E., and Levine, P. A. Chromosome 11Q13 amplification in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg., 119: 1238-1243, 1993.
13. Wang, X., Pavelic, Z. P., Li, Y., Gleich, L., Gartside, P. S., Pavelic, L., Gluckman, J. L., and Stambrook, P. J. Overexpression and amplification of glutathione S-transferase π gene in head and neck squamous cell carcinomas. Clin. Cancer Res., 3: 111-114, 1997.
14. Nishimura, T., Newkirk, K., Sessions, R. B., Andrews, P. A., Trock, B. J., Rasmussen, A. A., Montgomery, E. A., Bischoff, E. K., and Cullen, K. J. Immunohistochemical staining for glutathione S-transferase predicts response to platinum based chemotherapy in head and neck cancer. Clin. Cancer Res., 2: 1859-1865, 1996.
15. Shiga, H., Heath, E. I., Rasmussen, A. A., Trock, B., Johnston, P. G., Forastiere, A. A., Langmacher, M., Baylor, A., Lee, M., and Cullen, K. J. Prognostic value of p53, glutathione S-transferase π, and thymidylate synthase for neoadjuvant cisplatin-based chemotherapy in head and neck cancer. Clin. Cancer Res., 5: 4097-4104, 1999.
16. Newkirk, K., Heffern, J., Sloman-Moll, E., Sessions, R. B., Rasmussen, A. A., Andrews, P. A., and Cullen, K. J. Glutathione content but not γ-glutamylcysteine synthetase mRNA expression predicts cisplatin resistance in head and neck cell lines. Cancer Chemother. Pharmacol., 40: 75-80, 1997.
17. Tietze, F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem., 27: 502-522, 1969.
18. Figueiredo, B. C., Stratakis, C. A., Sandrini, R., DeLacerda, L., Pianovsky, M. A., Young, H., and Haddad, B. Comparative genomic hybridization (CGH) analysis of adrenocortical tumors of childhood. J. Clin. Endocrinol. Metab., 84: 1116-1121, 1999.
19. Liu, J., Cavalli, L. R., Haddad, B. R., and Papadopoulos, V. Molecular cloning, genomic organization, chromosomal mapping and subcellular localization of mouse PAP7: a PBR and PKA-RIα associated protein. Gene (Amst.), 308: 1-10, 2003.
20. Bell, K. A., Van Deerlin, P., Haddad, B., and Feinberg, R. F. Cytogenetic diagnosis of "Normal 46, XX" karyotypes in spontaneous abortions may frequently be misleading. Fertil. Steril., 71: 334-341, 1999.
21. Bockmuhl, U., Schluns, K., Schmidt, S., Matthias, S., and Petersen, I. Chromosomal alterations during metastasis formation of head and neck squamous cell carcinoma. Genes Chromosomes Cancer, 33: 29-35, 2002.
22. Struski, S., Doco-Fenzy, M., and Cornillet-Lefebvre, P. Compilation of published comparative genomic hybridization studies. Cancer Genet. Cytogenet., 135: 63-90, 2002.
23. Izzo, J. G., Papadimitrakopoulou, V. A., Li, X. Q., Ibarguen, H., Lee, J. S., Ro, J. Y., El-Naggar, A., Hong, W. K., and Hittelman, W. N. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene, 17: 2313-2322, 1998.
24. Akervall, J., Bockmuhl, U., Petersen, I., Yang, K., Carey, T. E., and Kurnit, D. M. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck. Clin. Cancer Res., 9: 1750-1755, 2003.
25. Sartelet, H., Grossi, L., Pasquier, D., Combaret, V., Bouvier, R., Ranchere, D., Plantaz, D., Munzer, M., Philip, T., Birembaut, P., Zahm, J. M., Bergeron, C., Gaillard, D., and Pasquier, B. Detection of N-myc amplification by FISH in immature areas of fixed neuroblastomas: more efficient than Southern blot/PCR. J. Pathol., 198: 83-91, 2002.
26. Goto, S., Kamada, K., Soh, Y., Ihara, Y., and Kondo, T. Significance of nuclear glutathione S-transferase π in resistance to anti-cancer drugs. Jpn. J. Cancer Res., 93: 1047-1056, 2002.